A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
New images of one of the brain’s fastest-acting proteins—the kainate receptor—are providing critical clues that may lead to targeted therapies for epilepsy and other brain disorders.
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
One of the most important molecules in the brain doesn’t work quite the way scientists thought it did, according to new work by researchers at Columbia and Carnegie Mellon.
What is cannabis good for? Columbia’s cannabis research director explains cannabinoids, CBD, THC, cannabis use disorder, potential therapeutic uses of marijuana, and more.
Heavy ions could radically improve radiation therapy for cancer treatment, but research is needed to understand how they work. With the aid of a new instrument at Columbia, scientists aim to find out.
Columbia researchers have uncovered how Gram-negative bacteria—which cause a variety of drug-resistant infections—build their protective outer layer, which could lead to more effective treatments.
COVID patients who remain unresponsive after receiving respiratory support may require long time periods to regain consciousness; delays are related to blood oxygen levels.
Two early-career scientists at Columbia University Vagelos College of Physicians and Surgeons—Minoree Kohwi, PhD, and Chao Lu, PhD—have been awarded prestigious 2022 Hirschl Trust Research Awards.
What was learned by researchers during the pandemic has changed the mindset for scientists: “Why do we have to follow the old routine when we see a new paradigm working so well?”
COVID vaccines and monoclonal antibody treatments offer less protection against new omicron subvariants, a new study from researchers at Columbia and University of Hong Kong finds.